Literature DB >> 23727169

Chronic kidney disease: global dimension and perspectives.

Vivekanand Jha1, Guillermo Garcia-Garcia, Kunitoshi Iseki, Zuo Li, Saraladevi Naicker, Brett Plattner, Rajiv Saran, Angela Yee-Moon Wang, Chih-Wei Yang.   

Abstract

Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated to be 8-16% worldwide. Complications include increased all-cause and cardiovascular mortality, kidney-disease progression, acute kidney injury, cognitive decline, anaemia, mineral and bone disorders, and fractures. Worldwide, diabetes mellitus is the most common cause of chronic kidney disease, but in some regions other causes, such as herbal and environmental toxins, are more common. The poorest populations are at the highest risk. Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced. Awareness of the disorder, however, remains low in many communities and among many physicians. Strategies to reduce burden and costs related to chronic kidney disease need to be included in national programmes for non-communicable diseases.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23727169     DOI: 10.1016/S0140-6736(13)60687-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  1166 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

Review 2.  Genetic testing for kidney disease of unknown etiology.

Authors:  Thomas Hays; Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2020-04-24       Impact factor: 10.612

3.  A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.

Authors:  Yiming Zhou; Philip Castonguay; Eriene-Heidi Sidhom; Abbe R Clark; Moran Dvela-Levitt; Sookyung Kim; Jonas Sieber; Nicolas Wieder; Ji Yong Jung; Svetlana Andreeva; Jana Reichardt; Frank Dubois; Sigrid C Hoffmann; John M Basgen; Mónica S Montesinos; Astrid Weins; Ashley C Johnson; Eric S Lander; Michael R Garrett; Corey R Hopkins; Anna Greka
Journal:  Science       Date:  2017-12-08       Impact factor: 47.728

Review 4.  Environmental exposures and pediatric kidney function and disease: A systematic review.

Authors:  Laura Y Zheng; Alison P Sanders; Jeffrey M Saland; Robert O Wright; Manish Arora
Journal:  Environ Res       Date:  2017-07-17       Impact factor: 6.498

5.  Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Authors:  Justyna Siwy; Joost P Schanstra; Angel Argiles; Stephan J L Bakker; Joachim Beige; Petr Boucek; Korbinian Brand; Christian Delles; Flore Duranton; Beatriz Fernandez-Fernandez; Marie-Luise Jankowski; Mohammad Al Khatib; Thomas Kunt; Maria Lajer; Ralf Lichtinghagen; Morten Lindhardt; David M Maahs; Harald Mischak; William Mullen; Gerjan Navis; Marina Noutsou; Alberto Ortiz; Frederik Persson; John R Petrie; Johannes M Roob; Peter Rossing; Piero Ruggenenti; Ivan Rychlik; Andreas L Serra; Janet Snell-Bergeon; Goce Spasovski; Olivera Stojceva-Taneva; Matias Trillini; Heiko von der Leyen; Brigitte M Winklhofer-Roob; Petra Zürbig; Joachim Jankowski
Journal:  Nephrol Dial Transplant       Date:  2014-03-02       Impact factor: 5.992

6.  Urinary Sodium and Potassium Excretion and CKD Progression.

Authors:  Jiang He; Katherine T Mills; Lawrence J Appel; Wei Yang; Jing Chen; Belinda T Lee; Sylvia E Rosas; Anna Porter; Gail Makos; Matthew R Weir; L Lee Hamm; John W Kusek
Journal:  J Am Soc Nephrol       Date:  2015-09-17       Impact factor: 10.121

7.  Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Charles R Swanepoel; Mohamed G Atta; Vivette D D'Agati; Michelle M Estrella; Agnes B Fogo; Saraladevi Naicker; Frank A Post; Nicola Wearne; Cheryl A Winkler; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christina M Wyatt
Journal:  Kidney Int       Date:  2018-02-03       Impact factor: 10.612

8.  microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression.

Authors:  Soumya Maity; Amit Bera; Nandini Ghosh-Choudhury; Falguni Das; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Exp Cell Res       Date:  2018-02-01       Impact factor: 3.905

9.  Assessment of Global Kidney Health Care Status.

Authors:  Aminu K Bello; Adeera Levin; Marcello Tonelli; Ikechi G Okpechi; John Feehally; David Harris; Kailash Jindal; Babatunde L Salako; Ahmed Rateb; Mohamed A Osman; Bilal Qarni; Syed Saad; Meaghan Lunney; Natasha Wiebe; Feng Ye; David W Johnson
Journal:  JAMA       Date:  2017-05-09       Impact factor: 56.272

Review 10.  Radiological manifestations of renal osteodystrophy in the orofacial region: a case report and literature review.

Authors:  Meng You; Bei Tang; Zi-Jiang Wang; Kai-Li Wang; Hu Wang
Journal:  Oral Radiol       Date:  2017-06-24       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.